![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/26 | |
A61K 38/57 | |||
A61K 9/28 | |||
A61K 9/48 | |||
A61K 31/202 | |||
A61K 31/22 | |||
A61P 3/04 | |||
A61P 3/10 |
(11) | Patento numeris | 2300031 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09742563.1 |
Europos patento paraiškos padavimo data | 2009-05-03 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-03-30 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-20 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IL2009/000461 |
Data | 2009-05-03 |
(87) | Numeris | WO 2009/136392 |
Data | 2009-11-12 |
(30) | Numeris | Data | Šalis |
71538 P | 2008-05-05 | US |
(72) |
KIDRON, Miriam, IL
|
(73) |
Oramed Ltd.,
Givat Ram 2/5 High Tech Park, 91390 Jerusalem,
IL
|
(54) | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE |